0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Genomic and Proteomic Tool - Global Market Insights and Sales Trends 2024
Published Date: December 2023
|
Report Code: QYRE-Auto-0M13087
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Genomic and Proteomic Tool Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Genomic and Proteomic Tool - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-0M13087
Report
December 2023
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Genomic and Proteomic Tool - Market

Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.
The global Genomic and Proteomic Tool market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic and Proteomic Tool in various end use industries. The expanding demands from the Research Labs and Institutes, Drug Discovery, Bioinformatics and Others, are propelling Genomic and Proteomic Tool market. Genomics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Proteomics segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomic and Proteomic Tool market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomic and Proteomic Tool market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic and Proteomic Tool, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Genomic and Proteomic Tool market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic and Proteomic Tool market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic and Proteomic Tool sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic and Proteomic Tool covered in this report include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare and QIAGEN NV, etc.
The global Genomic and Proteomic Tool market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3billion, Inc.
Bio-Rad Laboratories, Inc.
Lucigen Corp.
Macrogen, Inc.
Abbott
Thermal Fisher Scientific, Inc.
Bio-Synthesis, Inc.
GE Healthcare
QIAGEN NV
Novogene Corp.
Waters Corp.
OriGene Technologies
Takara Bio, Inc.
Vela Diagnostics

Scope of Genomic and Proteomic Tool - Market Report

Report Metric Details
Report Name Genomic and Proteomic Tool - Market
Global Genomic and Proteomic Tool market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic and Proteomic Tool market, Segment by Type:
  • Genomics
  • Proteomics
Global Genomic and Proteomic Tool market, by Application
  • Research Labs and Institutes
  • Drug Discovery
  • Bioinformatics
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Genomic and Proteomic Tool companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What are the Application segmentation covered in the Genomic and Proteomic Tool - Market report?

Ans: The Applications covered in the Genomic and Proteomic Tool - Market report are Research Labs and Institutes, Drug Discovery, Bioinformatics, Others

What are the Type segmentation covered in the Genomic and Proteomic Tool - Market report?

Ans: The Types covered in the Genomic and Proteomic Tool - Market report are Genomics, Proteomics

1 Market Overview of Genomic and Proteomic Tool
1.1 Genomic and Proteomic Tool Market Overview
1.1.1 Genomic and Proteomic Tool Product Scope
1.1.2 Genomic and Proteomic Tool Market Status and Outlook
1.2 Global Genomic and Proteomic Tool Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomic and Proteomic Tool Market Size by Region (2018-2029)
1.4 Global Genomic and Proteomic Tool Historic Market Size by Region (2018-2023)
1.5 Global Genomic and Proteomic Tool Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomic and Proteomic Tool Market Size (2018-2029)
1.6.1 North America Genomic and Proteomic Tool Market Size (2018-2029)
1.6.2 Europe Genomic and Proteomic Tool Market Size (2018-2029)
1.6.3 Asia-Pacific Genomic and Proteomic Tool Market Size (2018-2029)
1.6.4 Latin America Genomic and Proteomic Tool Market Size (2018-2029)
1.6.5 Middle East & Africa Genomic and Proteomic Tool Market Size (2018-2029)
2 Genomic and Proteomic Tool Market by Type
2.1 Introduction
2.1.1 Genomics
2.1.2 Proteomics
2.2 Global Genomic and Proteomic Tool Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomic and Proteomic Tool Historic Market Size by Type (2018-2023)
2.2.2 Global Genomic and Proteomic Tool Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomic and Proteomic Tool Revenue Breakdown by Type (2018-2029)
3 Genomic and Proteomic Tool Market Overview by Application
3.1 Introduction
3.1.1 Research Labs and Institutes
3.1.2 Drug Discovery
3.1.3 Bioinformatics
3.1.4 Others
3.2 Global Genomic and Proteomic Tool Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomic and Proteomic Tool Historic Market Size by Application (2018-2023)
3.2.2 Global Genomic and Proteomic Tool Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomic and Proteomic Tool Revenue Breakdown by Application (2018-2029)
4 Genomic and Proteomic Tool Competition Analysis by Players
4.1 Global Genomic and Proteomic Tool Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2022)
4.3 Date of Key Players Enter into Genomic and Proteomic Tool Market
4.4 Global Top Players Genomic and Proteomic Tool Headquarters and Area Served
4.5 Key Players Genomic and Proteomic Tool Product Solution and Service
4.6 Competitive Status
4.6.1 Genomic and Proteomic Tool Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 3billion, Inc.
5.1.1 3billion, Inc. Profile
5.1.2 3billion, Inc. Main Business
5.1.3 3billion, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.1.4 3billion, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.1.5 3billion, Inc. Recent Developments
5.2 Bio-Rad Laboratories, Inc.
5.2.1 Bio-Rad Laboratories, Inc. Profile
5.2.2 Bio-Rad Laboratories, Inc. Main Business
5.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.2.4 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.2.5 Bio-Rad Laboratories, Inc. Recent Developments
5.3 Lucigen Corp.
5.3.1 Lucigen Corp. Profile
5.3.2 Lucigen Corp. Main Business
5.3.3 Lucigen Corp. Genomic and Proteomic Tool Products, Services and Solutions
5.3.4 Lucigen Corp. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.3.5 Macrogen, Inc. Recent Developments
5.4 Macrogen, Inc.
5.4.1 Macrogen, Inc. Profile
5.4.2 Macrogen, Inc. Main Business
5.4.3 Macrogen, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.4.4 Macrogen, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.4.5 Macrogen, Inc. Recent Developments
5.5 Abbott
5.5.1 Abbott Profile
5.5.2 Abbott Main Business
5.5.3 Abbott Genomic and Proteomic Tool Products, Services and Solutions
5.5.4 Abbott Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Recent Developments
5.6 Thermal Fisher Scientific, Inc.
5.6.1 Thermal Fisher Scientific, Inc. Profile
5.6.2 Thermal Fisher Scientific, Inc. Main Business
5.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.6.4 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.6.5 Thermal Fisher Scientific, Inc. Recent Developments
5.7 Bio-Synthesis, Inc.
5.7.1 Bio-Synthesis, Inc. Profile
5.7.2 Bio-Synthesis, Inc. Main Business
5.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.7.4 Bio-Synthesis, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Synthesis, Inc. Recent Developments
5.8 GE Healthcare
5.8.1 GE Healthcare Profile
5.8.2 GE Healthcare Main Business
5.8.3 GE Healthcare Genomic and Proteomic Tool Products, Services and Solutions
5.8.4 GE Healthcare Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.8.5 GE Healthcare Recent Developments
5.9 QIAGEN NV
5.9.1 QIAGEN NV Profile
5.9.2 QIAGEN NV Main Business
5.9.3 QIAGEN NV Genomic and Proteomic Tool Products, Services and Solutions
5.9.4 QIAGEN NV Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.9.5 QIAGEN NV Recent Developments
5.10 Novogene Corp.
5.10.1 Novogene Corp. Profile
5.10.2 Novogene Corp. Main Business
5.10.3 Novogene Corp. Genomic and Proteomic Tool Products, Services and Solutions
5.10.4 Novogene Corp. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.10.5 Novogene Corp. Recent Developments
5.11 Waters Corp.
5.11.1 Waters Corp. Profile
5.11.2 Waters Corp. Main Business
5.11.3 Waters Corp. Genomic and Proteomic Tool Products, Services and Solutions
5.11.4 Waters Corp. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.11.5 Waters Corp. Recent Developments
5.12 OriGene Technologies
5.12.1 OriGene Technologies Profile
5.12.2 OriGene Technologies Main Business
5.12.3 OriGene Technologies Genomic and Proteomic Tool Products, Services and Solutions
5.12.4 OriGene Technologies Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.12.5 OriGene Technologies Recent Developments
5.13 Takara Bio, Inc.
5.13.1 Takara Bio, Inc. Profile
5.13.2 Takara Bio, Inc. Main Business
5.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Products, Services and Solutions
5.13.4 Takara Bio, Inc. Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.13.5 Takara Bio, Inc. Recent Developments
5.14 Vela Diagnostics
5.14.1 Vela Diagnostics Profile
5.14.2 Vela Diagnostics Main Business
5.14.3 Vela Diagnostics Genomic and Proteomic Tool Products, Services and Solutions
5.14.4 Vela Diagnostics Genomic and Proteomic Tool Revenue (US$ Million) & (2018-2023)
5.14.5 Vela Diagnostics Recent Developments
6 North America
6.1 North America Genomic and Proteomic Tool Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Genomic and Proteomic Tool Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomic and Proteomic Tool Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomic and Proteomic Tool Market Dynamics
11.1 Genomic and Proteomic Tool Industry Trends
11.2 Genomic and Proteomic Tool Market Drivers
11.3 Genomic and Proteomic Tool Market Challenges
11.4 Genomic and Proteomic Tool Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Genomic and Proteomic Tool Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Genomic and Proteomic Tool Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Genomic and Proteomic Tool Market Size Share by Region (2018-2023)
    Table 4. Global Genomic and Proteomic Tool Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Genomic and Proteomic Tool Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Genomic and Proteomic Tool Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Genomic and Proteomic Tool Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Genomic and Proteomic Tool Revenue Market Share by Type (2018-2023)
    Table 9. Global Genomic and Proteomic Tool Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Genomic and Proteomic Tool Revenue Market Share by Type (2024-2029)
    Table 11. North America Genomic and Proteomic Tool Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Genomic and Proteomic Tool Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Genomic and Proteomic Tool Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Genomic and Proteomic Tool Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Genomic and Proteomic Tool Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Genomic and Proteomic Tool Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Genomic and Proteomic Tool Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Genomic and Proteomic Tool Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Genomic and Proteomic Tool Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Genomic and Proteomic Tool Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Genomic and Proteomic Tool Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Genomic and Proteomic Tool Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Genomic and Proteomic Tool Revenue Market Share by Application (2018-2023)
    Table 24. Global Genomic and Proteomic Tool Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Genomic and Proteomic Tool Revenue Market Share by Application (2024-2029)
    Table 26. North America Genomic and Proteomic Tool Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Genomic and Proteomic Tool Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Genomic and Proteomic Tool Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Genomic and Proteomic Tool Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Genomic and Proteomic Tool Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Genomic and Proteomic Tool Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Genomic and Proteomic Tool Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Genomic and Proteomic Tool Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Genomic and Proteomic Tool Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Genomic and Proteomic Tool Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Genomic and Proteomic Tool Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Genomic and Proteomic Tool Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2022)
    Table 39. Date of Key Players Enter into Genomic and Proteomic Tool Market
    Table 40. Global Genomic and Proteomic Tool Key Players Headquarters and Area Served
    Table 41. Genomic and Proteomic Tool Product Solution and Service
    Table 42. Global Genomic and Proteomic Tool Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. 3billion, Inc. Basic Information List
    Table 45. 3billion, Inc. Description and Business Overview
    Table 46. 3billion, Inc. Genomic and Proteomic Tool Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Genomic and Proteomic Tool Business of 3billion, Inc. (2018-2023)
    Table 48. 3billion, Inc. Recent Developments
    Table 49. Bio-Rad Laboratories, Inc. Basic Information List
    Table 50. Bio-Rad Laboratories, Inc. Description and Business Overview
    Table 51. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Bio-Rad Laboratories, Inc. (2018-2023)
    Table 53. Bio-Rad Laboratories, Inc. Recent Developments
    Table 54. Lucigen Corp. Basic Information List
    Table 55. Lucigen Corp. Description and Business Overview
    Table 56. Lucigen Corp. Genomic and Proteomic Tool Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Lucigen Corp. (2018-2023)
    Table 58. Lucigen Corp. Recent Developments
    Table 59. Macrogen, Inc. Basic Information List
    Table 60. Macrogen, Inc. Description and Business Overview
    Table 61. Macrogen, Inc. Genomic and Proteomic Tool Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Macrogen, Inc. (2018-2023)
    Table 63. Macrogen, Inc. Recent Developments
    Table 64. Abbott Basic Information List
    Table 65. Abbott Description and Business Overview
    Table 66. Abbott Genomic and Proteomic Tool Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Abbott (2018-2023)
    Table 68. Abbott Recent Developments
    Table 69. Thermal Fisher Scientific, Inc. Basic Information List
    Table 70. Thermal Fisher Scientific, Inc. Description and Business Overview
    Table 71. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Thermal Fisher Scientific, Inc. (2018-2023)
    Table 73. Thermal Fisher Scientific, Inc. Recent Developments
    Table 74. Bio-Synthesis, Inc. Basic Information List
    Table 75. Bio-Synthesis, Inc. Description and Business Overview
    Table 76. Bio-Synthesis, Inc. Genomic and Proteomic Tool Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Bio-Synthesis, Inc. (2018-2023)
    Table 78. Bio-Synthesis, Inc. Recent Developments
    Table 79. GE Healthcare Basic Information List
    Table 80. GE Healthcare Description and Business Overview
    Table 81. GE Healthcare Genomic and Proteomic Tool Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Genomic and Proteomic Tool Business of GE Healthcare (2018-2023)
    Table 83. GE Healthcare Recent Developments
    Table 84. QIAGEN NV Basic Information List
    Table 85. QIAGEN NV Description and Business Overview
    Table 86. QIAGEN NV Genomic and Proteomic Tool Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Genomic and Proteomic Tool Business of QIAGEN NV (2018-2023)
    Table 88. QIAGEN NV Recent Developments
    Table 89. Novogene Corp. Basic Information List
    Table 90. Novogene Corp. Description and Business Overview
    Table 91. Novogene Corp. Genomic and Proteomic Tool Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Novogene Corp. (2018-2023)
    Table 93. Novogene Corp. Recent Developments
    Table 94. Waters Corp. Basic Information List
    Table 95. Waters Corp. Description and Business Overview
    Table 96. Waters Corp. Genomic and Proteomic Tool Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Waters Corp. (2018-2023)
    Table 98. Waters Corp. Recent Developments
    Table 99. OriGene Technologies Basic Information List
    Table 100. OriGene Technologies Description and Business Overview
    Table 101. OriGene Technologies Genomic and Proteomic Tool Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Genomic and Proteomic Tool Business of OriGene Technologies (2018-2023)
    Table 103. OriGene Technologies Recent Developments
    Table 104. Takara Bio, Inc. Basic Information List
    Table 105. Takara Bio, Inc. Description and Business Overview
    Table 106. Takara Bio, Inc. Genomic and Proteomic Tool Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Takara Bio, Inc. (2018-2023)
    Table 108. Takara Bio, Inc. Recent Developments
    Table 109. Vela Diagnostics Basic Information List
    Table 110. Vela Diagnostics Description and Business Overview
    Table 111. Vela Diagnostics Genomic and Proteomic Tool Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Genomic and Proteomic Tool Business of Vela Diagnostics (2018-2023)
    Table 113. Vela Diagnostics Recent Developments
    Table 114. North America Genomic and Proteomic Tool Market Size by Country (2018-2023) & (US$ Million)
    Table 115. North America Genomic and Proteomic Tool Market Size by Country (2024-2029) & (US$ Million)
    Table 116. Europe Genomic and Proteomic Tool Market Size by Country (2018-2023) & (US$ Million)
    Table 117. Europe Genomic and Proteomic Tool Market Size by Country (2024-2029) & (US$ Million)
    Table 118. Asia-Pacific Genomic and Proteomic Tool Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 119. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2018-2023) & (US$ Million)
    Table 120. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2024-2029) & (US$ Million)
    Table 121. Asia-Pacific Genomic and Proteomic Tool Market Share by Region (2018-2023)
    Table 122. Asia-Pacific Genomic and Proteomic Tool Market Share by Region (2024-2029)
    Table 123. Latin America Genomic and Proteomic Tool Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 124. Latin America Genomic and Proteomic Tool Market Size by Country (2018-2023) & (US$ Million)
    Table 125. Latin America Genomic and Proteomic Tool Market Size by Country (2024-2029) & (US$ Million)
    Table 126. Middle East & Africa Genomic and Proteomic Tool Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 127. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2018-2023) & (US$ Million)
    Table 128. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2024-2029) & (US$ Million)
    Table 129. Genomic and Proteomic Tool Market Trends
    Table 130. Genomic and Proteomic Tool Market Drivers
    Table 131. Genomic and Proteomic Tool Market Challenges
    Table 132. Genomic and Proteomic Tool Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genomic and Proteomic Tool Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Genomic and Proteomic Tool Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Genomic and Proteomic Tool Market Share by Regions: 2022 VS 2029
    Figure 4. Global Genomic and Proteomic Tool Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Genomic and Proteomic Tool Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Genomic and Proteomic Tool Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Genomic and Proteomic Tool Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Genomic and Proteomic Tool Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Genomic and Proteomic Tool Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Genomics
    Figure 11. Global Genomics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Proteomics
    Figure 13. Global Proteomics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Global Genomic and Proteomic Tool Market Size Share by Type: 2022 & 2029
    Figure 15. North America Genomic and Proteomic Tool Revenue Market Share by Type (2018-2029)
    Figure 16. Europe Genomic and Proteomic Tool Revenue Market Share by Type (2018-2029)
    Figure 17. Asia-Pacific Genomic and Proteomic Tool Revenue Market Share by Type (2018-2029)
    Figure 18. Latin America Genomic and Proteomic Tool Revenue Market Share by Type (2018-2029)
    Figure 19. Middle East and Africa Genomic and Proteomic Tool Revenue Market Share by Type (2018-2029)
    Figure 20. Research Labs and Institutes Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 21. Drug Discovery Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Bioinformatics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Global Genomic and Proteomic Tool Market Size Share by Application: 2022 & 2029
    Figure 25. North America Genomic and Proteomic Tool Revenue Market Share by Application (2018-2029)
    Figure 26. Europe Genomic and Proteomic Tool Revenue Market Share by Application (2018-2029)
    Figure 27. Asia-Pacific Genomic and Proteomic Tool Revenue Market Share by Application (2018-2029)
    Figure 28. Latin America Genomic and Proteomic Tool Revenue Market Share by Application (2018-2029)
    Figure 29. Middle East and Africa Genomic and Proteomic Tool Revenue Market Share by Application (2018-2029)
    Figure 30. Genomic and Proteomic Tool Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 31. Global Top 5 and Top 10 Players Genomic and Proteomic Tool Market Share in 2022
    Figure 32. North America Genomic and Proteomic Tool Market Share by Country (2018-2029)
    Figure 33. United States Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 34. Canada Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 35. Germany Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 36. France Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 37. U.K. Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 38. Italy Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 39. Russia Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 40. Nordic Countries Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 41. Asia-Pacific Genomic and Proteomic Tool Market Share by Region (2018-2029)
    Figure 42. China Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 43. Japan Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 44. South Korea Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 45. Southeast Asia Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 46. India Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 47. Australia Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 48. Latin America Genomic and Proteomic Tool Market Share by Country (2018-2029)
    Figure 49. Mexico Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 50. Brazil Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Genomic and Proteomic Tool Market Share by Country (2018-2029)
    Figure 52. Turkey Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 54. UAE Genomic and Proteomic Tool Market Size (2018-2029) & (US$ Million)
    Figure 55. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Plant-based Soft Capsule - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26V13549
Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Grade Sodium Hyaluronate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17N14065
Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Pharmaceutical Fluid Bed System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-6Q14792
Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Medical Microbial Incubators - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-30W13258
Thu Nov 07 00:00:00 UTC 2024

Add to Cart